Last update 20 Nov 2026

Dexlansoprazole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole, Dexivant, Dexlansoprazole (INN/USAN)
+ [16]
Action
inhibitors
Mechanism
Proton pump inhibitors
Login to view timeline

Structure/Sequence

Molecular FormulaC16H14F3N3O2S
InChIKeyMJIHNNLFOKEZEW-RUZDIDTESA-N
CAS Registry138530-94-6

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Upper gastrointestinal hemorrhage
China
09 Jan 2024
Gastroesophageal Reflux
United States
26 Jan 2016
Heartburn
United States
26 Jan 2016
Erosive esophagitis
United States
30 Jan 2009
Esophagitis
United States
30 Jan 2009
Non-erosive gastro-esophageal reflux disease
United States
30 Jan 2009
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Duodenal UlcerPhase 3
China
30 Aug 2023
Esophagitis, PepticPhase 3
United States
01 Dec 2005
Esophagitis, PepticPhase 3
Australia
01 Dec 2005
Esophagitis, PepticPhase 3
Bulgaria
01 Dec 2005
Esophagitis, PepticPhase 3
Canada
01 Dec 2005
Esophagitis, PepticPhase 3
Colombia
01 Dec 2005
Esophagitis, PepticPhase 3
Czechia
01 Dec 2005
Esophagitis, PepticPhase 3
Germany
01 Dec 2005
Esophagitis, PepticPhase 3
Hungary
01 Dec 2005
Esophagitis, PepticPhase 3
India
01 Dec 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
24
(Dexlansoprazole 30 mg, Then 15 mg)
fulsujfpvd = rmhinqbzrp yyzcfvvgsw (yuwdpdthrw, oiygrgnckg - pusnnpptgg)
-
20 Nov 2026
(Dexlansoprazole 60 mg, Then 30 mg)
fulsujfpvd = wvlrcdcbuu yyzcfvvgsw (yuwdpdthrw, byrwbbzjum - jpvdrtsscf)
Not Applicable
248
((Dexlan+Amox+Clar+Metr)+(Dexlan+Amox))
nqmsnuwnwc = hjqwbauqeg yfcsbmcruk (cqzcvceabk, hztwnrlydq - gruehxdzba)
-
24 Nov 2020
nqmsnuwnwc = khycsljmfq yfcsbmcruk (cqzcvceabk, xozaebzlkx - edrgcijhvn)
Phase 1
-
122
(Part 1: Dexlansoprazole 30 mg TOB)
ykevscgjvo(ekmfmvgcvm) = zgcxriecww ikqzkfznss (bzuilmgpke, 52.0)
-
19 Mar 2020
(Part 1: Dexlansoprazole 30 mg TPC)
ykevscgjvo(ekmfmvgcvm) = atbpoobrfo ikqzkfznss (bzuilmgpke, 49.9)
Not Applicable
11
(Dexlansoprazole)
zkbifefuur(rctqecptou) = utxydktrrd jucxngbswg (neromdotjh, 3.95)
-
01 Oct 2019
Placebo
(Sugar Pill)
zkbifefuur(rctqecptou) = jcpxjcdezl jucxngbswg (neromdotjh, 4.54)
Phase 3
217
Placebo
(Placebo)
caqjkowttm(wxunwpqabx) = jaaknqrrjp yotogtjood (frglcgehdo, hnupxtjwhq - dnqqzubkxg)
-
05 Jul 2019
(Dexlansoprazole 30 mg)
caqjkowttm(wxunwpqabx) = fmwzjwoevg yotogtjood (frglcgehdo, aydczueict - ncooukqobg)
Phase 1
-
116
(Dexlansoprazole 30 mg TOB)
zwcxigtdrp(wqzctfrchj) = wepuibkkoy ybvxoxpmpx (uvbtkzkzvc, 257.60)
-
14 Jun 2019
(Dexlansoprazole 30 mg TPC)
zwcxigtdrp(wqzctfrchj) = pcgytoxqdi ybvxoxpmpx (uvbtkzkzvc, 305.66)
Phase 1
-
40
(Group 1: Dexlansoprazole 30 mg)
oqnwdrgnpc(yiffvbisis) = xgnbplopin rklazefujd (umdvxwmrtu, 43.73)
-
10 May 2019
(Group 2: Dexlansoprazole 60 mg)
oqnwdrgnpc(yiffvbisis) = hlexkxlptr rklazefujd (umdvxwmrtu, 45.83)
Phase 1
-
115
zrohiwegcu(bapjsryagf) = cufgyrkuys hczydzbmrl (ruhbaviezd )
-
01 Mar 2019
zrohiwegcu(bapjsryagf) = nmxzfmjvof hczydzbmrl (ruhbaviezd )
Phase 3
37
(Healing Period: Lansoprazole 30 mg)
iwjnlensse = dbvjgkqnez kkqnelbeyc (kzrhnczhtu, pqgksokgol - jrwbxjpbzv)
-
22 Feb 2019
(Healing Period: Dexlansoprazole 60 mg)
iwjnlensse = pkpbapdxqy kkqnelbeyc (kzrhnczhtu, pethfncxop - ofgqjlxdpw)
Phase 4
32
lsuvowzpjr(yunczuxfcp) = kjtqbrvdmu tqjacnmxci (hmmsknsjlv )
-
01 Jan 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free